KCT0006890招募中未知
Morphine Titration with Intravenous Patient-Controlled Analgesia for Severe Cancer Pain
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19?(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Male or female over the age of 19 who provided written consent
- •2. If you have had cancer pain with an average NRS score of 7 or higher within the past 24 hours
- •3. Subjects who can accurately understand the pain intensity NRS and follow the drug use guide
- •4. A person who understands the purpose of this clinical trial and the procedures necessary for the clinical trial, and is able to sign and submit the informed consent form including the requirements and regulations listed in the consent form and this clinical trial protocol
排除标准
- •1. If there is a history of side effects such as decreased breathing with opioid analgesics
- •2. If you are taking a morphine equivalent daily dose (MEDD) of 300 mg/day or more
- •3. If the analgesic effect was not shown by previous administration or administration of morphine
- •4. Subjects with cognitive impairment or serious mental illness that will interfere with the progress of the study
- •5. Subjects who are pregnant, lactating, and planning to become pregnant within 1 month of participation in the study (including men)
- •6. Creatinine > 2 x upper limit of normal
- •7. Patients with severe respiratory depression
- •? Patients with acute and severe asthma and hypercapnia
- •? Patients with severe chronic obstructive airway disease
- •? Patients with severe chronic obstructive pulmonary disease and pulmonary heart disease
- •? If it is included in the following criteria in the lung function test
- •1. FEV1 / FVC < 70% or
- •2. FEV1 < 30% or
- •3. FEV1 <50% with chronic respiratory failure
- •8. Patients receiving MAO inhibitors at the time of screening or within 14 days of discontinuation of treatment
- •9. Patients with liver and biliary tract disease; Patients with moderate to severe hepatic impairment
- •? ALT or AST >3.0 x ULN
- •? Total bilirubin >1.5 x ULN
- •10. When the Investigator determines that other measures of pain control may be affected.
研究者
相似试验
进行中（未招募）
1 期
Topical administration of Morphine: Evaluation of the analgesic effect in children with stomatitis.Stomatitis as a side-effect to chemotherapy.MedDRA version: 8.1Level: LLTClassification code 10042128Term: StomatitisEUCTR2006-003260-53-SEThe Faculty of Pharmaceutical Sciences, University of Copenhagen75
招募中
不适用
Mixed Infusion with Morphineo specifications - all tumor patients receiving a mixed infusion with morphine as a result of tumor pain. Loss of effectiveness of morphine in mixed infusions and testing of clinical application.DRKS00009009niversitätsklinikum Freiburg10
已完成
4 期
A Comparison of Intrathecal Morphine with Intravenous Patient Control Analgesia (IV PCA) for Pain Control After Video-Assisted Thoracoscopic Surgery (VATS)intrathecal morphineThe patients undergoing elective VATSvideo-assisted thoracoscopic surgerypainmorphinepruritusTCTR20201005002/A38
招募中
3 期
Effect of morphin in prognose of Anterior MIAcute Anterior ST Elevatiom Myocardial Infarction.ST elevation (STEMI) myocardial infarction of anterior wallI21.0IRCT20230102057018N1Research Assistant of Tabriz University of Medical Sciences200
进行中（未招募）
不适用
Evaluation of Intranasal (IN) Morphine Sulphate as a Paramedic Administered Analgesic for Children in the Pre-Hospital Environment - Intranasal (IN) Morphine for Pre-Hospital Paediatric AnalgesiaThis research hopes to bridge the gap between in-hospital diamorphine and pre-hospital IV morphine by developing IN morphine for administration to children between 3 and 14 years old. This will allow effective non parental opiod analgesia to be used by paramedics.Main inclusion will be for children who are within paramedic IV morphine protocol, but who are refusing cannulation or for whom cannulation would be technically difficult or would cause unnecessary distress.EUCTR2005-002308-40-GBniversity of Plymouth80